Market Overview:
The global peptide therapeutics market reached a value of US$ 35.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 61.9 Billion by 2027, exhibiting a CAGR of 9.42% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Peptides are efficacious and selective signaling molecules that bind to specific cell surface receptors, such as ion channels and G protein-coupled receptors (GPCRs) and trigger intracellular effects. They are employed in the pharmaceutical industry to design novel regenerative therapeutics that can target a wide range of cells and manipulate their responses. These therapeutics are less toxic, relatively safe, and well-tolerated than other treatment options. As a result, they are gaining traction in clinical practices worldwide to manage cancer, injuries, infectious diseases, metabolic disorders, and aesthetic concerns.
Peptide Therapeutics Market Trends:
The growing prevalence of acute and chronic diseases, along with the rising access to medical facilities, represents one of the leading factors positively influencing the demand for peptides to develop innovative therapies. Moreover, peptides therapies are used in cosmeceutical surgeries to slow down the process of skin aging. This, coupled with the increasing consciousness among individuals about physical appearance and the desire to retain young and healthy skin, is driving the adoption of cosmetic surgeries and peptide therapeutics around the world. Apart from this, with the introduction of novel synthetic strategies that reduce injection frequency and improve stability and other physical properties, peptide therapeutics are widely being used in injections for diabetic patients. This, in confluence with the increasing incidence of diabetes and the growing preference for quick and precise treatment methods, is influencing the use of peptide therapeutics over oral medications. Furthermore, the emerging trend of personalized and targeted treatments is catalyzing the demand for multifunctional peptide-based materials. This, along with the rising funding to develop novel peptide therapeutics for treating autoimmune and inflammatory diseases, is projected to create a positive market outlook.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global peptide therapeutics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, type of manufacturer, synthesis technology, routes of administration and application.
Breakup by Type:
Breakup by Type of Manufacturer:
Breakup by Synthesis Technology:
- Solid Phase Peptide Synthesis
- Liquid Phase Peptide Synthesis
- Hybrid Technology
Breakup by Routes of Administration:
Breakup by Application:
- Gastrointestinal Disorders
- Neurological Disorders
- Metabolic Disorders
- Cancer
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Apitope International NV, Arch Biopartners Inc., AstraZeneca plc, Circle Pharma Inc., Corden Pharma GmbH, F. Hoffmann-La Roche AG, Ipsen Group, Lonza Group AG, Novo Nordisk A/S, Pfizer Inc., Teva Pharmaceuticals Industries Ltd. and Zealand Pharma A/S.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Type, Type of Manufacturer, Synthesis Technology, Routes of Administration, Application, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Amgen Inc., Apitope International NV, Arch Biopartners Inc., AstraZeneca plc, Circle Pharma Inc., Corden Pharma GmbH, F. Hoffmann-La Roche AG, Ipsen Group, Lonza Group AG, Novo Nordisk A/S, Pfizer Inc., Teva Pharmaceuticals Industries Ltd. and Zealand Pharma A/S |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global peptide therapeutics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global peptide therapeutics market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the type of manufacturer?
- What is the breakup of the market based on the synthesis technology?
- What is the breakup of the market based on the routes of administration?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global peptide therapeutics market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Peptide Therapeutics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Innovative
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Generic
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Type of Manufacturer
7.1 Outsourced
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 In-house
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Synthesis Technology
8.1 Solid Phase Peptide Synthesis
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Liquid Phase Peptide Synthesis
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Hybrid Technology
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Routes of Administration
9.1 Parenteral
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Oral
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Application
10.1 Gastrointestinal Disorders
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Neurological Disorders
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Metabolic Disorders
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Cancer
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Amgen Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Apitope International NV
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.3 Arch Biopartners Inc.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.4 AstraZeneca plc
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 Circle Pharma Inc.
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.6 Corden Pharma GmbH
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7 F. Hoffmann-La Roche AG
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 SWOT Analysis
16.3.8 Ipsen Group
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 Lonza Group AG
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Novo Nordisk A/S
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
16.3.10.4 SWOT Analysis
16.3.11 Pfizer Inc.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.11.4 SWOT Analysis
16.3.12 Teva Pharmaceuticals Industries Ltd.
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.12.4 SWOT Analysis
16.3.13 Zealand Pharma A/S
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
16.3.13.3 Financials
List of Figures
Figure 1: Global: Peptide Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Peptide Therapeutics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Peptide Therapeutics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Peptide Therapeutics Market: Breakup by Type (in %), 2021
Figure 5: Global: Peptide Therapeutics Market: Breakup by Type of Manufacturer (in %), 2021
Figure 6: Global: Peptide Therapeutics Market: Breakup by Synthesis Technology (in %), 2021
Figure 7: Global: Peptide Therapeutics Market: Breakup by Routes of Administration (in %), 2021
Figure 8: Global: Peptide Therapeutics Market: Breakup by Application (in %), 2021
Figure 9: Global: Peptide Therapeutics Market: Breakup by Region (in %), 2021
Figure 10: Global: Peptide Therapeutics (Innovative) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Peptide Therapeutics (Innovative) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Peptide Therapeutics (Generic) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Peptide Therapeutics (Generic) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Peptide Therapeutics (Outsourced) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Peptide Therapeutics (Outsourced) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Peptide Therapeutics (In-house) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Peptide Therapeutics (In-house) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Peptide Therapeutics (Solid Phase Peptide Synthesis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Peptide Therapeutics (Solid Phase Peptide Synthesis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Peptide Therapeutics (Liquid Phase Peptide Synthesis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Peptide Therapeutics (Liquid Phase Peptide Synthesis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Peptide Therapeutics (Hybrid Technology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Peptide Therapeutics (Hybrid Technology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Peptide Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Peptide Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Peptide Therapeutics (Oral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Peptide Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Peptide Therapeutics (Other Routes of Administration) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Peptide Therapeutics (Other Routes of Administration) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Peptide Therapeutics (Gastrointestinal Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Peptide Therapeutics (Gastrointestinal Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Peptide Therapeutics (Neurological Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Peptide Therapeutics (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Peptide Therapeutics (Metabolic Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Peptide Therapeutics (Metabolic Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Peptide Therapeutics (Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Peptide Therapeutics (Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: Peptide Therapeutics (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: Peptide Therapeutics (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: North America: Peptide Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: North America: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: United States: Peptide Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: United States: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Canada: Peptide Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Canada: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Asia-Pacific: Peptide Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Asia-Pacific: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: China: Peptide Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: China: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Japan: Peptide Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Japan: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: India: Peptide Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: India: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: South Korea: Peptide Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: South Korea: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Australia: Peptide Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Australia: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Indonesia: Peptide Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Indonesia: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Others: Peptide Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Europe: Peptide Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Europe: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Germany: Peptide Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Germany: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: France: Peptide Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: France: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: United Kingdom: Peptide Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: United Kingdom: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Italy: Peptide Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Italy: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Spain: Peptide Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Spain: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Russia: Peptide Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Russia: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Others: Peptide Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Latin America: Peptide Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Latin America: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Brazil: Peptide Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Brazil: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Mexico: Peptide Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Mexico: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Others: Peptide Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Middle East and Africa: Peptide Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 87: Middle East and Africa: Peptide Therapeutics Market: Breakup by Country (in %), 2021
Figure 88: Middle East and Africa: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Global: Peptide Therapeutics Industry: SWOT Analysis
Figure 90: Global: Peptide Therapeutics Industry: Value Chain Analysis
Figure 91: Global: Peptide Therapeutics Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Peptide Therapeutics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Peptide Therapeutics Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Peptide Therapeutics Market Forecast: Breakup by Type of Manufacturer (in Million US$), 2022-2027
Table 4: Global: Peptide Therapeutics Market Forecast: Breakup by Synthesis Technology (in Million US$), 2022-2027
Table 5: Global: Peptide Therapeutics Market Forecast: Breakup by Routes of Administration (in Million US$), 2022-2027
Table 6: Global: Peptide Therapeutics Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 7: Global: Peptide Therapeutics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 8: Global: Peptide Therapeutics Market: Competitive Structure
Table 9: Global: Peptide Therapeutics Market: Key Players